SAM #NOI-CC-OLAO-26-006059

Sole Source Procurement of Floxuridine 500mg Vials for NIH Clinical Center Patient Care

This notice details the NIH Clinical Center's intent to procure ten (10) vials of Floxuridine 500mg for injection, used in patient care, via a sole source contract. - The procurement is for Floxuridine 500mg vials, NDC 0143-9270-01 or 81643-9270-1, with a unit price of $4,177.00 per vial. - The total estimated contract value is $41,770. - The sole source vendor is Cardinal Health dba Specialty Pharmaceutical Services (JND Therapeutics), the exclusive U.S. distributor for this product. - Delivery is required within five business days of approval to the NIH Clinical Center in Bethesda, Maryland. - The acquisition is justified under 41 USC 501 and FAR 8.405-6 for limited competition, citing that no other supply or service will satisfy the agency's requirements. - This is not a request for proposal; it is a notice of intent to award on a sole source basis. - The product is a pharmaceutical injectable used for patient care at a federal medical facility. - The price update for this product is effective January 7, 2026.

Description

This is a Notice of Intent, not a request for proposal.  The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Cardinal Health dba Specialty Pharmaceutical Services (JND Therapeutics).

Acquisition Description:

The purpose of this acquisition is to purchase X10 VIALS of Floxuridine 500MG vials for injections for patient care.   

The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.  All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-006059) by 12:00 PM eastern standard time on 06/03/2026 to: valerie.gregorio@nih.gov.

All responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

View original listing